The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients

Journal of Investigative Dermatology

Volumn 113, Issue 5, 1999, Pages 752-759

  Austin, Lisa M ^a   Ozawa, Maki ^a   Kikuchi, Toyoko ^a   Walters, Ian B ^a   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Interleukin 10; Interleukin 4; Intracellular; Ratio

Indexed keywords

BREFELDIN A; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032729645     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00749.x     Document Type: Article

References (69)

1. Abdullah NA, Torres BA, Basu M, Johnson HM: Differential effects epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation interferon-gamma production. J Immunol 143:113-117, 1989
2. Asadullah K, Sterry W, Stephanek K, et al: IL-10 is a key cytokine in psoriasis. J Clin Invest 101:783-794, 1998
3. Austin LM, Coven TR, Bhardwaj N, Steinman R, Krueger JG: Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17 (TIA-1)+CD8+CD3+CTLs as determined by phenotypic analysis. J Cutan Pathol 25(2):79-88, 1998
4. Baker JN, Jones ML, Mitra PS, et al: Modulation keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139:869-876, 1991
5. Barker JNWN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ: Marked synergism between tumor necrosis factor-α and interferon-γ in regulation keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 85:605-608, 1990
6. Barna M, Snijdewint FGM, van der Heijden FL, Bos JD, Kapsenberg ML: Characterization lesional psoriatic skin T lymphocyte clones. Acta Dermatol Venereol (Stockh) Suppl. 186:9-11, 1994
7. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Intralesional T-lymphocyte activation as a mediator psoriatic epidermal hyperplasia. J Invest Dermatol 105:89S-94S, 1995a
8. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Kinetics and regulation human keratinocyte stem cell growth in short-term primary ex vivo culture. J Clin Invest 95:317-327, 1995b
9. Bennett SRM, Carbone FR, Karamalis F, Flavell RA, Miller JFAP, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-480, 1998
10. Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM: Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest 94:797-807, 1994
11. Bos JD, Ric MAD: The pathogenesis of psoriasis: Immunology and speculations. Immunol Today 20(1):40-46, 1999
12. Croft M, Carter I, Swain SL, Dutton RW: Generation polarized antigen-specific CD8 effector populations: Reciprocal action interleukin (IL) 4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715-1728, 1994
13. D'Elios M, Del Prete G: Th1/Th2 balance in human disease. Transplant Proc 30:2373-2377, 1998
14. Del Prete G: The concept type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 16(3-4):427-455, 1998
15. Dolhain RJEM, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AMM: Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints patients with rheumatoid arthritis. Arthritis Rheum 39:1961-1969, 1996
16. Ferry B, Antrobus P, Huzicka I, Farrell A, Lane A, Chapel H: Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis. Clin Exp Immunol 110:410-417, 1997
17. Fierlbeck G, Rassner G, Muller C: Psoriasis induced at the injection site recombinant interferon gamma. Results immunohistologic invests. Arch Dermatol 126:351-355, 1990
18. Gomi T, Shiohara T, Munakata T, Imanishi K, Nagashima M: Interleukin 1alpha, Tumor necrosis factor alpha and interferon gamma in psoriasis. Arch Dermatol 127:827-830, 1991
19. Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM: Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 164:1013-1028, 1986
20. Gottlieb AB, Luster AD, Posnett DN, Carter DM: Detection of a gamma interferon-induced protein (IP-10) in psoriatic plaques. J Invest Dermatol 90:565, 1988
21. Gottlieb S, Johnson R, Gilleaudeau P, Woodworth T, Nylen P, Gottlieb AB, Krueger JG: A specific lymphocyte toxin (DAB389IL-2) reverses epidermal keratinocyte activation in psoriasis: improvement correlates with elimination intraepidermal CD8+ lymphocytes. J Invest Dermatol 102:531, 1994
22. 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1:442-447, 1995
23. Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
24. Gross DM, Steere AC, Huber BT: T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 160:1022-1028, 1998
25. Grossman RM, Krueger J, Yourish D, et al: Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-6371, 1989
26. Groves RW, Allen MH, Ross EL, Barker JNWN, MacDonald DM: Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345-352, 1995
27. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV: Intracellular inactivation the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36, 1996
28. Guo J, Rapoport B, McLachlan SM: Cytokine profiles in vivo activated thyroid-infiltrating T cells cloned in the presence or absence interleukin 4. Autoimmunity 26:103-110, 1997
29. von Herrath MG, Allison J, Miller JFAP, Oldstone MBA: Focal expression interleukin 2 does not break unresponsiveness to 'self' (viral) antigen expressed in β cells but enhances development autoimmune disease (diabetes) after initiation an anti-self immune response. J Clin Invest 95:477-485, 1995
30. Jason J, Lamed J: Single-cell cytokine profiles in normal humans: comparison flow cytometric reagents and stimulation protocols. J Immunol Methods 207:13-22, 1997
31. Jones CD, Guckian M, El Ghorr AA, Gibbs NK, Norval M: Effects phototherapy on the production cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 12:204-210, 1996
32. Kelso A, Groves P: A single peripheral CD8+ T cell can give rise to progeny expressing type 1 and/or type 2 cytokine genes and can retain its multipotentiality through many cell divisions. Proc Natl Acad Sci USA 94:8070-8075, 1997
33. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM: Localization tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 94:354-362, 1993
34. Krueger JG, Wolfe JT, Nabeya RT, et al: Successful ultraviolet B treatment psonasis is accompanied by a reversal keratinocyte pathology and by selective depletion intraepidermal T cells. J Exp Med 182:2057-2068, 1995
35. Livden JK, Nilsen R, Bjerke JR, Matre R: In situ localization interferons in psoriatic lesions. Arch Dermatol Res 281:392-397, 1989
36. Michel L, Mencia-Huerta JM, Benveniste J, Dubertret L: Biologic properties LTB4 and paf-acether in vivo in human skin. J Invest Dermatol 88(6):675-681, 1987
37. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ: Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 154(6):2668-2677, 1995
38. Morita Y, Yamamura M, Kawashima M, et al: Flow cytometric single-cell analysis cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 41:1669-1676, 1998
39. Mosmann TR, Sad S: The expanding universe T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
40. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types murine helper T cell clone. 1. Definition according to profiles lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
41. + cells in the peripheral blood patients with atopic dermatitis. Exp Dermatol 7:112-118, 1998
42. + cells in patients with atopic dermatitis. J Allergy Clin Immunol 99:673-682, 1997
43. Nestle FO, Turka LA, Nickoloff BJ: Characterization dermal dendritic cells in psoriasis. Autostimulation T lymphocytes and induction Th1 type cytokines. J Clin Invest 94:202-209, 1994
44. Nickoloff BJ, Mitra RS: Intraepidermal psoriatic cytokine network involves gamma interferon, transforming growth factor-alpha, and their cell surface receptors: Dysregulation rather than deficiency. J Invest Dermatol 99:882-883, 1992
45. Nickoloff BJ, Mitra RS, Elder JT, Fisher GJ, Voorhees JJ: Decreased growth inhibition by recumbinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Br J Dermatol 121:161-174, 1989
46. Nickoloff BJ, Karabin GD, Barker JN, et al: Cellular localization interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138:129-140, 1991
47. + T cells from normal and immunodeficient donors using directly conjugated anti cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 105:517-522, 1996
48. Olaniran AK, Baker BS, Paige DG, Garioch JJ, Powles AV, Fry L: Cytokine expression in psoriatic skin lesions during PUVA therapy. Arch Dermatol Res 288:421-425, 1996
49. + macrophages into the epidermis. Arch Dermatol Res 284:375-379, 1992
50. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC: Direct demonstration cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408-1419, 1995
51. Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G: T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 24:593-598, 1994
52. Prussin C: Cytokine flow cytometry: Understanding cytokine biology at the single-cell level. J Clin Immunol 17:195-204, 1997
53. Prussin C, Metcalfe DD: Detection intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188:117-128, 1995
54. Res PC, Struijk L, Leow A, Daha MR, van den Elsen PC, Breedveld FC: Inflamed joints patients with rheumatoid arthritis contain T cells that display in vitro proliferation to antigens present in autologous synovial fluid. Functional analysis on the basis synovial-fluid-reactive T-cell clones and lines. Hum Immunol 40:291-298, 1994
55. + T-helper and a T-killer cell. Nature 393:474-477, 1998
56. Roura-Mir C, Catalfamo M, Sospedra M, Alcalde L, Pujol-Borrell R, Jaraquemada D: Single-cell analysis intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. Eur J Immunol 27:3290-3302, 1997
57. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR: Differing lymphokine profiles functional subsets human CD4 and CD8 T cell clones. Science 254:279-282, 1991
58. Sato A, Tsuji K, Yamamura M, et al: Increased type 2 cytokine expression by both CD4+ CD45RO + T cells and CD8+ CD45RO + T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis. J Invest Dermatol 111(6):1079-1084, 1998
59. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Bueschenfelde K-H: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-149, 1994
60. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483, 1998
61. Schoendorf T, Engel H, Lindemann C, van Kolhagen H, Ruecker AA, Mallmann P: Cellular characteristics peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours. Cancer Immunol Immunother 44:88-96, 1997
62. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M: Increased frequencies interleukin-2- and interferon-γ-producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci 39:996-1004, 1998
63. Sunder-Plassmann R, Breiteneder H, Zimmermann K, Strunk D, Majdic O, Knapp W, Holter W: Single human T cells stimulated in the absence feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokiue stimulation. Blood 87:5179-5184, 1996
64. Suni MA, Picker LJ, Maino VC: Detection antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 212:89-98, 1998
65. + subsets. J Invest Dermatol 111:1072-1078, 1998
66. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-705, 1993
67. Vollmer S, Menssen A, Trommler P, Schendel D, Prinz JC: T lymphocytes derived from skin lesion patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from T helper type 1 and T helper type 2 cells. Eur J Immunol 24:2377-2382, 1994
68. + T lymphocytes in atopic patients. J Immunol 144:4651-4656, 1990
69. Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR: Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 111:1053-1057, 1998